INGN
Inogen Inc
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Best Orthopedic Devices Stocks 2026 →
Inogen (INGN) Stock: Buy, Sell, or Hold?
$5.81
-0.19 (-3.17%)
▼
5d:
-19.53%
30d:
-8.36%
90d:
+0.0%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (57%)
Quality Score
40/100
Position
OVERSOLD
30-Day Fair Range
$5.80 – $7.01
Position: OVERSOLD
Forward P/E & Valuation
-37.5x
CHEAP
vs 120.2x historical avg
Wall Street Target
$12.00
+100.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$5.05 / $7.44
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: INGN is down 19.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When INGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: INGN is currently trading at $5.81, which is considered oversold relative to its 30-day fair value range of $5.80 to $7.01. From a valuation perspective, the stock is trading at a discount (Forward PE: -37.5) compared to its historical average (120.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INGN is showing sideways momentum. Immediate support is located at $5.05, while resistance sits at $7.44. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: INGN scores 24/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+100.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INGN is showing sideways momentum. Immediate support is located at $5.05, while resistance sits at $7.44. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: INGN scores 24/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+100.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.80 -
$7.01
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.1%
Trading Range & Key Levels
30-Day Trading Range
$5.80 -
$7.01
Current vs Trading Range
OVERSOLD
Support Level
$5.05
Resistance Level
$7.44
Current Trend
Sideways
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (24/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 100.0% below Wall St target ($12.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-37.50
Wall Street Target
$12.00
(+100.0%)
Revenue Growth (YoY)
-16.4%
Earnings Growth (YoY)
87.3%
Profit Margin
-10.0%
PE vs Historical
-37.5 vs 120.2
CHEAP
Share INGN Analysis
Share this live INGN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INGN)
Bullish
4 Retail Mentions
Reddit / WSB Comments
2
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Jul 24, 2026
Daily AI digest
AI Retail Discussion Summary:
Inogen reported Q4 revenue of $81.7 million, up 2% year-over-year, with international sales up 15% and U.S. rentals down 4.5%. Management introduced a new share repurchase authorization.
Key Retail Themes:
Revenue growth
International sales
Share repurchase
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 10:28 AM ET
Data refreshes hourly during market hours. Next update: 11:28 AM
Data refreshes hourly during market hours. Next update: 11:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 35 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 43 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INGN Research Pages
